Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rush University Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
ECOG 0-2
Patients must be planning to receive standard of car e neoadjuvant chemotherapy as defined by the most recent version of NCCN guidelines (www.nccn.org)
Patients must have histologically or cytologically confirmed invasive breast cancer that is either triple-negative or HER2+ (regardless of hormone receptor status)
You may not be if
Patients with any uncontrolled intercurrent illness.
Patients who have any underlying medical condition for which, in the investigator's opinion, participation would not be in the best interest of the participant
History of egg allergy
Patients currently on anticoagulant therapy, corticosteroids, or immunosuppressive agents
History of allergic reactions attributed to compounds of similar chemical or biologic composition to the seasonal flu vaccine.
History of Guillain-Barré syndrome
Clareo Health | A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
